AbbVie's $10.9 Billion Apogee Deal Tests Dividend King Resolve
AbbVie announced on June 22 that it will acquire Apogee Therapeutics for $10.9 billion in cash, adding zumilokibart, an investigational eczema treatme
Apogee Therapeutics
Every Fin-node story mentioning Apogee Therapeutics — 1 story, newest first.
Apogee Therapeutics · 1 story